COMPARISON OF COST- EFFICACY OF SUBCUTANEOUS ABATACEPT VERSUS ADALIMUMAB IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Khanna, D. [1 ]
Massarotti, E. [2 ]
Rosenblatt, L. [3 ]
Budd, D. [3 ]
Sabater, J. [4 ]
Hebden, T. [3 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Bristol Myers Squibb Co, Princeton, NJ USA
[4] Bristol Myers Squibb Int, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：340 / 341
页数：2
相关论文
共 50 条
  • [31] EFFICACY, SAFETY AND PHARMACOKINETICS OF SUBCUTANEOUS ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS, WITH OR WITHOUT AN INTRAVENOUS LOADING DOSE
    Nash, P.
    Ludivico, C.
    Delaet, I.
    Qi, K.
    Murthy, B.
    Corbo, M.
    Kaine, J.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 12 - 12
  • [32] COST PER RESPONSE FOR ABATACEPT VERSUS ADALIMUMAB IN PATIENTS WITH SEROPOSITIVE EROSIVE, EARLY RHEUMATOID ARTHRITIS IN THE UNITED STATES, GERMANY, SPAIN AND CANADA
    Foo, Jason
    Rodriguez-Heredia, Jose M. R.
    Polance Sanchez, Carlos
    Mtibaa, Mondher
    Herrmann, Kirsten H.
    Alernaoe, Eve
    Postema, Roelien
    Baerwald, Christoph
    RHEUMATOLOGY, 2018, 57
  • [33] Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis
    Charles-Schoeman, C.
    Gugiu, G. B.
    Ge, H.
    Shahbazian, A.
    Lee, Y. Y.
    Wang, X.
    Furst, D. E.
    Ranganath, V. K.
    Maldonado, M.
    Lee, Terry
    Reddy, S. T.
    ATHEROSCLEROSIS, 2018, 275 : 107 - 114
  • [34] ABATACEPT FOR THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN ARGENTINA: A COST-EFFECTIVENESS ANALYSIS
    Elgart, J. F.
    Gonzalez, L.
    Aiello, E. C.
    VALUE IN HEALTH, 2013, 16 (03) : A223 - A224
  • [35] Comparison of Intravenous Versus Subcutaneous Abatacept for the Treatment of Rheumatoid Arthritis in a Routine Clinical Care Setting: A Preliminary, Time to Response Analysis
    Swearingen, Christopher J.
    Poon, Jessica
    Bernstein, Hannah
    Yazici, Yusuf
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [36] Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients
    Takahashi, Nobunori
    Kojima, Toshihisa
    Terabe, Kenya
    Kaneko, Atsushi
    Kida, Daihei
    Hirano, Yuji
    Fujibayashi, Takayoshi
    Yabe, Yuichiro
    Takagi, Hideki
    Oguchi, Takeshi
    Miyake, Hiroyuki
    Kato, Takefumi
    Fukaya, Naoki
    Ishikawa, Hisato
    Hayashi, Masatoshi
    Tsuboi, Seiji
    Kato, Daizo
    Funahashi, Koji
    Matsubara, Hiroyuki
    Hattori, Yosuke
    Hanabayashi, Masahiro
    Hirabara, Shinya
    Yoshioka, Yutaka
    Ishiguro, Naoki
    MODERN RHEUMATOLOGY, 2013, 23 (05) : 904 - 912
  • [37] SEARCHING PREDICTORS OF ABATACEPT EFFICACY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Borisova, M.
    Lukina, G.
    Sigidin Y A, Y.
    Aronova, E.
    Luchihina, E.
    Karateev, D.
    Novikov, A.
    Alexandrova, E.
    Cherkasova, M.
    Glukhova, S.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1312 - 1312
  • [38] Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada
    Weijers, Laure
    Baerwald, Christoph
    Mennini, Francesco S.
    Rodriguez-Heredia, Jose M.
    Bergman, Martin J.
    Choquette, Denis
    Herrmann, Kirsten H.
    Attina, Giulia
    Nappi, Carmela
    Jimenez Merino, Silvia
    Patel, Chad
    Mtibaa, Mondher
    Foo, Jason
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (07) : 1111 - 1123
  • [39] Subcutaneous abatacept in rheumatoid arthritis: current update
    Keystone, Edward
    Alkhalaf, Abdulaziz
    Makkawy, Mosaab
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (08) : 1221 - 1230
  • [40] Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada
    Laure Weijers
    Christoph Baerwald
    Francesco S. Mennini
    José M. Rodríguez-Heredia
    Martin J. Bergman
    Denis Choquette
    Kirsten H. Herrmann
    Giulia Attinà
    Carmela Nappi
    Silvia Jimenez Merino
    Chad Patel
    Mondher Mtibaa
    Jason Foo
    Rheumatology International, 2017, 37 : 1111 - 1123
12345